Evaluation of MDFA’s education courses for health professionals
Read MoreEvaluation of MDFA’s education courses for health professionals
Read MoreVabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia
Read MoreMDFA 2022 research update
Read MoreAttend any medical congress and you’ll increasingly hear the terms “artificial intelligence” and “digital diagnosis”
Read MoreOphthalmologists needed for IVI digital support program
Read MoreMDFA is partnering with MyInteract to provide targeted digital information and resources directly to people receiving intravitreal injections (IVI).
Read MoreFree vision screenings at NSW Parliament House on World Sight Day.
Read MoreMDFA’s successful advocacy leading to the new Government’s rejection of the proposal to cut the MBS rebate for intravitreal injections leaves us with the question: what next?
Read MoreMDFA is committing to macular disease research
Read More